Rex Steffen, Missant Carlo, Claus Piet, Buhre Wolfgang, Wouters Patrick F
Department of Acute Medical Sciences, Centre for Experimental Anaesthesiology, Emergency and Intensive Care Medicine, Catholic University Leuven, Minderbroedersstraat, 3000 Leuven, Belgium.
Crit Care. 2008;12(5):R113. doi: 10.1186/cc7005. Epub 2008 Sep 10.
Prostacyclin inhalation is increasingly used to treat acute pulmonary hypertension and right ventricular failure, although its pharmacodynamic properties remain controversial. Prostacyclins not only affect vasomotor tone but may also have cAMP-mediated positive inotropic effects and modulate autonomic nervous system tone. We studied the role of these different mechanisms in the overall haemodynamic effects produced by iloprost inhalation in an experimental model of acute pulmonary hypertension.
In this prospective, randomized, placebo-controlled animal study, twenty-six pigs (mean weight 35 +/- 2 kg) were instrumented with biventricular conductance catheters, a pulmonary artery flow probe and a high-fidelity pulmonary artery pressure catheter. The effects of inhaled iloprost (50 microg) were studied in the following groups: animals with acute hypoxia-induced pulmonary hypertension, and healthy animals with and without blockade of the autonomic nervous system.
During pulmonary hypertension, inhalation of iloprost resulted in a 51% increase in cardiac output compared with placebo (5.6 +/- 0.7 versus 3.7 +/- 0.8 l/minute; P = 0.0013), a selective reduction in right ventricular afterload (effective pulmonary arterial elastance: 0.6 +/- 0.3 versus 1.2 +/- 0.5 mmHg/ml; P = 0.0005) and a significant increase in left ventricular end-diastolic volume (91 +/- 12 versus 70 +/- 20 ml; P = 0.006). Interestingly, right ventricular contractility was reduced after iloprost-treatment (slope of preload recruitable stroke work: 2.2 +/- 0.5 versus 3.4 +/- 0.8 mWatt.s/ml; P = 0.0002), whereas ventriculo-vascular coupling remained essentially preserved (ratio of right ventricular end-systolic elastance to effective pulmonary arterial elastance: 0.97 +/- 0.33 versus 1.03 +/- 0.15). In healthy animals, inhaled iloprost had only minimal haemodynamic effects and produced no direct effects on myocardial contractility, even after pharmacological blockade of the autonomic nervous system.
In animals with acute pulmonary hypertension, inhaled iloprost improved global haemodynamics primarily via selective pulmonary vasodilatation and restoration of left ventricular preload. The reduction in right ventricular afterload is associated with a paradoxical decrease in right ventricular contractility. Our data suggest that this reflects an indirect mechanism by which ventriculo-vascular coupling is maintained at the lowest possible energetic cost. We found no evidence for a direct negative inotropic effect of iloprost.
尽管前列环素的药效学特性仍存在争议,但吸入前列环素越来越多地用于治疗急性肺动脉高压和右心室衰竭。前列环素不仅影响血管运动张力,还可能具有环磷酸腺苷(cAMP)介导的正性肌力作用,并调节自主神经系统张力。我们在急性肺动脉高压实验模型中研究了这些不同机制在吸入伊洛前列素产生的整体血流动力学效应中的作用。
在这项前瞻性、随机、安慰剂对照动物研究中,26头猪(平均体重35±2千克)植入双心室电导导管、肺动脉血流探头和高保真肺动脉压力导管。在以下几组中研究吸入伊洛前列素(50微克)的效果:急性缺氧诱导的肺动脉高压动物,以及自主神经系统未阻断和已阻断的健康动物。
在肺动脉高压期间,与安慰剂相比,吸入伊洛前列素使心输出量增加51%(5.6±0.7对3.7±0.8升/分钟;P=0.0013),右心室后负荷选择性降低(有效肺动脉弹性:0.6±0.3对1.2±0.5毫米汞柱/毫升;P=0.0005),左心室舒张末期容积显著增加(91±12对70±20毫升;P=0.006)。有趣的是,伊洛前列素治疗后右心室收缩力降低(前负荷可募集搏功斜率:2.2±0.5对3.4±0.8毫瓦·秒/毫升;P=0.0002),而心室-血管耦合基本保持不变(右心室收缩末期弹性与有效肺动脉弹性之比:0.97±0.33对1.03±0.15)。在健康动物中,吸入伊洛前列素仅产生最小的血流动力学效应,即使在自主神经系统进行药理学阻断后,对心肌收缩力也无直接影响。
在急性肺动脉高压动物中,吸入伊洛前列素主要通过选择性肺血管舒张和恢复左心室前负荷改善整体血流动力学。右心室后负荷降低与右心室收缩力的矛盾性降低有关。我们的数据表明,这反映了一种间接机制,通过该机制心室-血管耦合以尽可能低的能量成本维持。我们没有发现伊洛前列素有直接负性肌力作用的证据。